Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1073-1079

  Lim, Sung Chul ^a   Park, Sung Yong ^a   Do, Nam Yong ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2; Head and neck; Prognosis; Squamous cell carcinoma; Vascular endothelial growth factor

Indexed keywords

CYCLOOXYGENASE 2; FLUORESCEIN; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOPLASM; FEMALE; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS; PROTEIN BINDING; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLOOXYGENASE 2; CYTOPLASM; FEMALE; FLUORESCEIN; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN BINDING; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2142805769     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1073     Document Type: Article

References (38)

1. Williams CS, Mann M and DuBois RN: The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18: 7908-7916, 1999. (Pubitemid 30066236)
2. Martin-Sanz P, Callejas NA, Casado M, Diaz-Guerra MJ and Bosca L: Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. Br J Pharmacol 125: 1313-1319, 1998. (Pubitemid 28542542)
3. Langenbach R, Loftin CD, Lee C and Tiano H: Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann NY Acad Sci 889: 52-61, 1999. (Pubitemid 30040425)
4. Callejas NA, Casado M, Diaz-Guerra MJM, Bosca L and Martin-Sanz P: Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 33: 860-867, 2001. (Pubitemid 32246635)
5. Sheng H, Shao J, Morrow JD, Beauchamp RD and DuBois RN: Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58: 362-366, 1998. (Pubitemid 28047080)
6. Sawaoka H, Kawano S, Tsuji S, et al: Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 274: G1061-G1067, 1998.
7. Battu S, Rigaud M and Beneytout JL: Resistance to apoptosis and cyclo-oxygenase-2 expression in a human adenocarcinoma cell line HT29CL.19A. Anticancer Res 18: 3579-3583, 1998. (Pubitemid 28546493)
8. Erikson BA, Longo WE, Panesar N, Mazuski JE and Kaminski DL: The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. J Surg Res 81: 101-107, 1999. (Pubitemid 29393786)
9. Liu XH, Yao S, Kirschenbaum A and Levine AC: NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 58: 4245-4249, 1998. (Pubitemid 28450018)
10. Sheng GG, Shao J, Sheng H, et al: A selective cyclooxygenase-2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology 113: 1883-1891, 1997. (Pubitemid 27512146)
11. Kinoshita T, Takahashi Y, Sakashita T, Inoue H, Tanabe T and Yoshimoto T: Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenase-1 and -2 in human colon carcinoma cells. Biochem Biophys Acta 1438: 120-130, 1999. (Pubitemid 29238523)
12. Masferrer JL, Leahy KM, Koki AT, et al: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 1306-1311, 2000. (Pubitemid 30151999)
13. Senger DR, van de Water L, Brown LF, et al: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324, 1993. (Pubitemid 23293287)
14. Dameron KM, Olpert OV, Tainsky MA and Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584, 1994. (Pubitemid 24308973)
15. Beahrs OH, Henson DE, Hutter RVP and Kennedy BJ (eds): Manual for staging for cancer. American Joint Committee on Cancer. 4th edition. J.B. Lippincott, Philadelphia, 1992.
16. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue. Cancer Res 46: 467-473, 1986.
17. Zatterstrom UK, Brun E, Willen R, et al: Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 17: 312-318, 1995.
18. Keck PJ, Hauser SD, Krivi G, et al: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989. (Pubitemid 20066717)
19. Senger DR, Galli SJ, Dvorak AM, et al: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitic fluid. Science 219: 983-985, 1983.
20. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
21. Dvorak HF, Orenstein NS, Carvalho AC, et al: Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor secreted by products. J Immunol 122: 166-174, 1979. (Pubitemid 9078536)
22. Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 3: 1806-1814, 1991.
23. Horak E, Leek R, Klenk N, Lejeune S, Smith K and Stuart N: Angiogenesis assessed by platelet endothelial cell adhesion molecule antibodies, as an indicator of node metastasis and survival in breast cancer. Lancet 340: 1120-1124, 1992.
24. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A and Trapasso F: Upregulation of vascular endothelial growth factor and down regulation of placenta growth factor associated with malignancy in human thyroid tumors and cell lines. Oncogene 11: 1569-1579, 1995.
25. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG and Werner S: Regulation of VEGF expression in cultured keratinocytes. Implication for normal and impaired wound healing. J Biol Chem 270: 12607-12613, 1995.
26. Kieser A, Weich HA, Brandner G, Marme D and Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994. (Pubitemid 24065938)
27. Dvorak HF, Harvey VS, Extrella P, et al: Fibrin containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. Lab Invest 57: 673-686, 1987. (Pubitemid 18031786)
28. Dvorak HF: Tumors: wounds that do not heal. Similarity between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1658, 1986.
29. Salven P, Heikkila P, Anttonen A, Kajanti M and Joensuu H: Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 10: 1128-1133, 1997. (Pubitemid 27521291)
30. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V and Masini E: Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3: 53-61, 2001. (Pubitemid 32201610)
31. Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S and Herlyn M: Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 5: 775-782, 1999. (Pubitemid 29180828)
32. Obermair A, Kucera E, Mayerhofer K, et al: Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. Int J Cancer 22: 455-458, 1997. (Pubitemid 27400169)
33. Gleich LL, Biddinger PW, Duperier FD and Gluckman JL: Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation. Head Neck 19: 276-280, 1997. (Pubitemid 27273105)
34. Graeber TG, Osmanian C, Jacks T, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379: 88-91, 1996. (Pubitemid 26008141)
35. Pepper MS, Ferrara N, Orci L and Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902-906 1991.
36. Mandriota SJ, Seghezzi G, Vassalli JD, et al: Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270: 9709-9716, 1995.
37. Ben-Av P, Crofford LJ, Wilder RL and Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 372: 83-87, 1995.
38. Goodwin JS and Ceuppens J: Regulation of the immune response by prostaglandins. J Clin Immunol 3: 295-314, 1983.